Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 238

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 238
---
 under the symbol “BIAFW.”
Our Common Stock and Tradeable Warrants trade on The Nasdaq Capital Market.

Holders
of Record

As
of March 17, 2025, there were approximately 92 holders of record of shares of our Common Stock. This number does not reflect
the beneficial holders of our Common Stock who hold shares in street name through brokerage accounts or other nominees.

Dividends

We
have never declared or paid any cash dividends on our capital stock. We intend to retain all available funds and future earnings, if
any, to fund the development and expansion of our business, and we do not anticipate declaring or paying any cash dividends in the foreseeable
future. Any future determination regarding the declaration and payment of dividends, if any, will be at the discretion of our Board of
Directors and will depend on then-existing conditions, including our financial condition, results of operations, contractual restrictions,
capital requirements, business prospects, and other factors our Board of Directors may deem relevant.

Unregistered
Sales of Equity Securities

We
did not sell any equity securities during the quarter ended December 31, 2024, in transactions that were not registered under the Securities
Act other than as previously disclosed in our filings with the SEC.

Securities
Authorized for Issuance Under Equity Compensation Plans

The
following table presents information as of December 31, 2024, with respect to shares of our Common Stock that may be issued under our equity incentive plans.

    Plan category 
    Number of securities to be issued upon exercise of outstanding options, warrants, and rights  
    Weighted-average exercise price of outstanding options, warrants, and rights  
    Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) 

    (a)  
    (b)  
    (c) 
  
    Equity compensation plans approved by security holders  

    2024 Equity Incentive Plan 
     519,792  
    $2.00  
     1,480,208 
  
    2014 Equity
Incentive Plan 
     380,132  
    $5.78  
     — 
  
    Equity compensation plans not approved by security holders 
     —  
     —  
     — 
  
    Total 
     899,924  
    $3.59  
     1,480,208 

Item
6